217 related articles for article (PubMed ID: 21878516)
1. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone.
Sundaram K; Shanmugarajan S; Rao DS; Reddy SV
Endocrinology; 2011 Nov; 152(11):4180-9. PubMed ID: 21878516
[TBL] [Abstract][Full Text] [Related]
2. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J
Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
4. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
[TBL] [Abstract][Full Text] [Related]
5. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
[TBL] [Abstract][Full Text] [Related]
6. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profile in osteoclasts from patients with Paget's disease of bone.
Michou L; Chamoux E; Couture J; Morissette J; Brown JP; Roux S
Bone; 2010 Mar; 46(3):598-603. PubMed ID: 19925894
[TBL] [Abstract][Full Text] [Related]
8. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.
Sambandam Y; Sundaram K; Saigusa T; Balasubramanian S; Reddy SV
Bone; 2017 Aug; 101():236-244. PubMed ID: 28506889
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.
Shanmugarajan S; Youssef RF; Pati P; Ries WL; Rao DS; Reddy SV
J Cell Biochem; 2008 Jul; 104(4):1500-8. PubMed ID: 18348201
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.
Jin W; Chang M; Paul EM; Babu G; Lee AJ; Reiley W; Wright A; Zhang M; You J; Sun SC
J Clin Invest; 2008 May; 118(5):1858-66. PubMed ID: 18382763
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Paget's disease of bone.
Ralston SH
Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibition suppress microgravity elevated RANK signaling during osteoclast differentiation.
Ethiraj P; Ottinger AM; Singh T; Singh A; Haire KM; Reddy SV
Cytokine; 2020 Jan; 125():154821. PubMed ID: 31470364
[TBL] [Abstract][Full Text] [Related]
13. p62/sequestosome 1 deficiency accelerates osteoclastogenesis
Zach F; Polzer F; Mueller A; Gessner A
J Biol Chem; 2018 Jun; 293(24):9530-9541. PubMed ID: 29555685
[TBL] [Abstract][Full Text] [Related]
14. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S
Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897
[TBL] [Abstract][Full Text] [Related]
15. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding.
Rea SL; Walsh JP; Ward L; Magno AL; Ward BK; Shaw B; Layfield R; Kent GN; Xu J; Ratajczak T
J Bone Miner Res; 2009 Jul; 24(7):1216-23. PubMed ID: 19257822
[TBL] [Abstract][Full Text] [Related]
16. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD
Cell Metab; 2011 Jan; 13(1):23-34. PubMed ID: 21195346
[TBL] [Abstract][Full Text] [Related]
17. Insights into the pathogenesis of Paget's disease.
Roodman GD
Ann N Y Acad Sci; 2010 Mar; 1192():176-80. PubMed ID: 20392234
[TBL] [Abstract][Full Text] [Related]
18. Effect of a rare genetic variant of TM7SF4 gene on osteoclasts of patients with Paget's disease of bone.
Laurier E; Amiable N; Gagnon E; Brown JP; Michou L
BMC Med Genet; 2017 Nov; 18(1):133. PubMed ID: 29145829
[TBL] [Abstract][Full Text] [Related]
19. Etiology of Paget's disease and osteoclast abnormalities.
Reddy SV
J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
[TBL] [Abstract][Full Text] [Related]
20. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]